![ICAP Grand Rounds Webinar (archived recording): ECHO Trial Results and Lessons Learned](https://icap.columbia.edu/wp-content/uploads/Webinar-Recordings-e1532366618694-1080x675.png)
Eswatini
![ICAP Grand Rounds Webinar (archived recording): ECHO Trial Results and Lessons Learned](https://icap.columbia.edu/wp-content/uploads/Webinar-Recordings-e1532366618694-1080x675.png)
![July 2019: ECHO trial of three contraceptive methods finds no significant difference in HIV incidence but alarmingly high incidence overall](https://icap.columbia.edu/wp-content/uploads/echo-article-header-1080x675.png)
July 2019: ECHO trial of three contraceptive methods finds no significant difference in HIV incidence but alarmingly high incidence overall
Article and Study Summary HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: A randomised, multicentre, open-label trial. Published in: The Lancet. Published...![Field Validation of Limiting-Antigen Avidity Enzyme Immunoassay to Estimate HIV-1 Incidence in Cross-Sectional Survey in Swaziland](https://icap.columbia.edu/wp-content/uploads/feb-2019-jc-header-3-1080x675.png)
Field Validation of Limiting-Antigen Avidity Enzyme Immunoassay to Estimate HIV-1 Incidence in Cross-Sectional Survey in Swaziland
Duong Pottinger Y, Dobbs T, Mavengere Y, Manjengwa J, Rottinghaus EK, Saito S, Bock N, Philip N, Justman J, Bicego G, Nkengasong JN, Parekh B. AIDS Res Hum Retroviruses. 2019 Jun 17. doi: 10.1089/AID.2018.0284. [Epub ahead of print] Abstract Reliable and...![HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial](https://icap.columbia.edu/wp-content/uploads/ECHO-lancet-header-1080x675.png)
HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial
Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium Site Principal Investigators: eSwatini, Manzini: Jessica Justman MD, Zelda Nhlabatsi MS (ICAP at Columbia University, New York, NY, USA, & Family Life Association of Eswatini) Lancet. 2019...![Healthcare worker experiences with Option B+ for prevention of mother-to-child HIV transmission in eSwatini: findings from a two-year follow-up study](https://icap.columbia.edu/wp-content/uploads/42736473345_b2c114dabe_k-1080x675.jpg)